FORT LAUDERDALE, Fla., June 3, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced that Ian Dawson has been appointed to the position of Senior Vice President of Marketing, assuming responsibility for MAKO's commercial marketing activities, which were formerly overseen by Ivan Delevic, who is transitioning to the position of Senior Vice President of Corporate Development. Mr. Dawson and Mr. Delevic will report to Maurice R. Ferré, M.D., MAKO's President and Chief Executive Officer.
MAKO Surgical Corp. Announces Addition Of Senior Executive To Management Team
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts